상처 치료 생물학 시장 - 글로벌 시장 - 산업 동향 및 2029년까지의 예측

글로벌 상처 치료 생물학적 제제 시장, 제품별(생물학적 피부 대체제, 국소 제제), 상처 유형(궤양, 수술 및 외상 상처, 화상), 최종 사용자(병원, ASC, 화상 센터 및 상처 클리닉) - 2029년까지의 산업 동향 및 예측

상처 치료 생물학 시장

시장 분석 및 규모

당뇨병은 모든 선진국과 농업국에서 공통적인 불법적 관계로 발전했습니다. 당뇨병은 해마다 더 흔해지고 있으며, 치료 시장의 주요 참여자들에게 길을 열어주고 있습니다. 상처 치료 생물학 시장은 수혜자 중 하나입니다. 증가하는 당뇨병 인구는 글로벌 상처 치료 생물학 시장 성장을 촉진하는 주요 요인으로 여겨집니다. 수많은 당뇨병 환자가 당뇨병성 궤양으로 고통받으며, 이는 경미한 수술과 확신이 필요합니다. 의료 시술 후 환자의 상처는 일반적으로 치유를 위한 약물이 들어 있는 띠로 덮입니다. 상처 치료 생물학은 치료 생산성을 개선하는 데 도움이 되는 이러한 품목을 제공합니다.

Data Bridge Market Research는 상처 치료 생물학 시장이 2029년까지 31억 1천만 달러 규모에 도달할 것으로 예상하며, 예측 기간 동안 CAGR은 3.80%라고 분석했습니다. 화상 부상자 수의 증가는 상처 치료 생물학 시장 성장을 촉진하고 있습니다.

시장 정의

상처 치유는 콜라겐 응고 및 침전, 상피화, 섬유 조직 부착, 상처 수축, 염증 사건, 조직 과립화 및 리모델링과 같은 수많은 세포 내, 세포 외 및 세포 간 요소의 동기화 및 활성화를 포함하는 복잡한 과정입니다. 상처 치료 생물학적 제제는 치유되지 않는 하지 상처를 치료하는 데 사용되는 생물학적으로 조작된 제품입니다.

보고 범위 및 시장 세분화

보고서 메트릭	세부
예측 기간	2022년부터 2029년까지
기준 연도	2021
역사적 연도	2020 (2019-2014까지 사용자 정의 가능)
양적 단위	매출은 백만 달러, 볼륨은 단위, 가격은 달러로 표시
다루는 세그먼트	제품별(생물학적 피부 대체제, 국소제), 상처 유형(궤양, 수술 및 외상 상처, 화상), 최종 사용자(병원, ASC, 화상 센터 및 상처 클리닉)
적용 국가	미국, 북미의 캐나다 및 멕시코, 독일, 프랑스, 영국, 네덜란드, 스위스, 벨기에, 러시아, 이탈리아, 스페인, 터키, 유럽의 기타 유럽 국가, 중국, 일본, 인도, 한국, 싱가포르, 말레이시아, 호주, 태국, 인도네시아, 필리핀, 아시아 태평양(APAC)의 기타 아시아 태평양 국가(APAC), 사우디 아라비아, UAE, 남아프리카 공화국, 이집트, 이스라엘, 중동 및 아프리카(MEA)의 일부인 중동 및 아프리카(MEA)의 기타 중동 및 아프리카(MEA), 남아메리카의 일부인 브라질, 아르헨티나 및 남아메리카의 기타 국가.
시장 참여자 포함	Smith & Nephew(영국), Mölnlycke Health Care AB(스웨덴), Integra LifeSciences Corporation(미국), Wright Medical(미국), MiMedx Group(미국), Vericel Corporation(미국), Anika Therapeutics(미국), Osiris Therapeutics(미국), Organogenesis(미국), Kerecis(아이슬란드), Solsys Medical(미국), ACell(미국), Lavior Inc.(미국). Marine Polymer Technologies, Inc.(미국), Smith & Nephew(영국), Mölnlycke Health Care AB(스웨덴)

기회	인구 내 유전병 감지 증가
	개인 가처분 소득 증가와 다양한 혁신 도입 기술을 통합하기 위한 의료 분야 연구

상처 치료 생물학 시장 동향

운전자

당뇨병 발병률 증가

상처 치료 생물학 시장 성장을 주도하는 주요 요인 중 하나는 상처 치료 및 관리 프로그램의 증가입니다. 비만, 열악한 식단, 신체 활동 부족으로 인한 당뇨병 발병률의 증가와 당뇨병 인구 중 만성 상처, 특히 발궤양의 증가가 시장 성장을 주도하고 있습니다.

더 나은 치료 옵션 개발

시장은 또한 더 나은 치료 옵션 개발에 대한 강조, 질병의 막대한 부담, 염증, 조직 축적, 콜라겐 축적 및 상피 세포층 형성을 처리하기 위한 기술 사용에 의해 영향을 받습니다.

의료 상호 운용성을 위한 정부 투자

연방 정부가 이러한 솔루션 채택을 촉진하기 위해 자금을 늘리면서 시장에 더 큰 영향을 미칩니다. 또한 의료비 지출의 급증, 의료 인프라의 발전, 확대된 치료 제공에 대한 높은 수요는 상처 치료 생물학 시장에 긍정적인 영향을 미칩니다.

기회

의료 인프라의 개선, 생명공학 부문에 대한 투자 증가, 의료비 지출 증가는 모두 수익성 있는 사업 기회에 긍정적인 영향을 미칩니다.

제약/도전

상처 치료 및 상처 관리 생물학적 제제의 높은 비용은 시장 성장을 저해할 것으로 예상되는 요인입니다. 예측 기간 동안 피부 대체 실패의 위험은 상처 관리 생물학적 제제 시장에 도전이 될 것으로 예상됩니다.

이 상처 치료 생물학 시장 보고서는 최근의 새로운 개발, 무역 규정, 수출입 분석, 생산 분석, 가치 사슬 최적화, 시장 점유율, 국내 및 지역 시장 참여자의 영향, 새로운 수익 창출처, 시장 규정의 변화, 전략적 시장 성장 분석, 시장 규모, 범주 시장 성장, 응용 분야 틈새 시장 및 지배력, 제품 승인, 제품 출시, 지리적 확장, 시장의 기술 혁신에 대한 분석 기회를 제공합니다. 상처 치료 생물학 시장에 대한 자세한 정보를 얻으려면 Data Bridge Market Research에 연락하여 분석가 브리핑을 받으세요. 저희 팀은 시장 성장을 달성하기 위한 정보에 입각한 시장 결정을 내리는 데 도움을 드립니다.

COVID-19가 상처 치료 생물학 시장에 미치는 영향

제약 및 바이오 기술 회사는 전 세계 정부와 협력하여 백신 개발부터 의약품 공급망 과제 계획까지 COVID-19 발병에 대처하기 위해 노력하고 있습니다. 현재 약 115개의 백신 후보와 155개의 분자가 R&D 파이프라인에 있습니다. 또한 히드록시클로로퀸과 같은 일반적으로 사용되는 약물은 COVID-19 관리에 대한 수요가 극적으로 증가했습니다. 많은 선진국에서 이러한 약물이 부족하기 때문에 높은 수요는 COVID-19 관리 약물 제조업체에 엄청난 기회를 창출했습니다. 제약 및 바이오 기술 산업은 COVID-19 백신 및 치료제에 대한 수요로 인해 앞으로 상당히 성장할 것으로 예상됩니다.

글로벌 상처 치료 생물학 시장 범위

상처 치료 생물학 시장은 제품, 상처 유형 및 최종 사용자를 기준으로 세분화됩니다. 이러한 세그먼트 간의 성장은 산업의 빈약한 성장 세그먼트를 분석하고 사용자에게 귀중한 시장 개요와 시장 통찰력을 제공하여 핵심 시장 응용 프로그램을 식별하기 위한 전략적 결정을 내리는 데 도움이 됩니다.

제품

생물학적 피부 대체제
국소제

제품을 기준으로, 상처 치료 생물학적 제제 시장은 생물학적 피부 대체제와 국소 제제로 세분화됩니다. 생물학적 피부 대체제는 인간 기증 조직 유래 제품, 무세포 동물 유래 제품 및 생합성 제품으로 더 세분화됩니다.

상처 유형

궤양
수술 및 외상 상처
번스

상처 유형에 따라 상처 관리 생물학적 제제 시장은 궤양, 수술 및 외상성 상처와 화상으로 세분화됩니다. 정맥성 궤양은 궤양, 당뇨성 발궤양, 압박성 궤양 및 기타 궤양으로 더 세분화됩니다.

최종 사용자

병원
ASCs
화상 센터
상처클리닉
기타

최종 사용자를 기준으로 상처 치료 생물학적 제제 시장은 병원, ASC, 화상 센터, 상처 클리닉으로 구분됩니다.

상처 치료 생물학 시장 지역 분석/통찰력

상처 치료 생물학적 제제 시장을 분석하고, 국가, 제품, 상처 유형 및 최종 사용자별로 시장 규모에 대한 통찰력과 추세를 제공합니다. 위에 참조된 내용입니다.

상처 치료 생물학적 제제 시장 보고서에서 다루는 국가는 다음과 같습니다. 북미의 미국, 캐나다 및 멕시코, 유럽의 독일, 프랑스, 영국, 네덜란드, 스위스, 벨기에, 러시아, 이탈리아, 스페인, 터키, 유럽의 기타 유럽 국가, 중국, 일본, 인도, 한국, 싱가포르, 말레이시아, 호주, 태국, 인도네시아, 필리핀, 아시아 태평양(APAC)의 기타 아시아 태평양(APAC), 사우디 아라비아, UAE, 남아프리카 공화국, 이집트, 이스라엘, 중동 및 아프리카(MEA)의 일부인 기타 중동 및 아프리카(MEA), 남아메리카의 일부인 기타 남아메리카.

북미는 당뇨병성 족부궤양의 유병률이 증가하고 미생물 및 진균성 피부 감염에 대한 감수성이 증가함에 따라 제품과 상처 유형을 지배합니다. 아시아 태평양 지역은 중국, 일본, 인도와 같은 신흥국이 존재하고 의료 인프라가 개발되고 있어 2021-2028년 예측 기간 동안 성장할 것으로 예상됩니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

의료 인프라 성장 설치 기반 및 신기술 침투

상처 치료 생물학 시장은 또한 모든 국가에 대한 자세한 시장 분석을 제공합니다. 자본 장비에 대한 의료 지출 증가, 상처 치료 생물학 시장을 위한 다양한 종류의 제품 설치 기반, 수명선 곡선을 사용한 기술의 영향, 의료 규제 시나리오의 변화 및 상처 치료 생물학 시장에 미치는 영향. 이 데이터는 2010-2020년의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 상처 치료 생물학 시장 점유율 분석

상처 치료 생물학 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 제공된 위의 데이터 포인트는 상처 치료 생물학 시장과 관련된 회사의 초점에만 관련이 있습니다.

상처 치료 생물학 시장에서 운영되는 주요 업체 중 일부는 다음과 같습니다.

스미스앤네퓨(영국)
Mölnlycke Health Care AB(스웨덴)
인테그라 라이프사이언스 코퍼레이션(미국)
라이트 메디컬(미국)
MiMedx 그룹(미국)
베리셀 코퍼레이션(미국)
아니카 테라퓨틱스(미국)
오시리스 테라퓨틱스(미국)
기관발생학(미국)
케레시스(아이슬란드)
솔시스메디컬(미국)
ACell(미국)
라비오르 주식회사(미국)
Marine Polymer Technologies, Inc. (미국)
스미스앤네퓨(영국)
Mölnlycke Health Care AB(스웨덴)

SKU-23247

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

Click on image to enlarge

대화형 데이터 분석 대시보드
높은 성장 잠재력 기회를 위한 회사 분석 대시보드
사용자 정의 및 질의를 위한 리서치 분석가 액세스
대화형 대시보드를 통한 경쟁자 분석
최신 뉴스, 업데이트 및 추세 분석
포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용

데모 요청

TABLE OF CONTENTS GLOBAL WOUND CARE BIOLOGICS MARKET

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL WOUND CARE BIOLOGICS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.1 DBMR MARKET POSITION GRID
2.2 DBMR MARKET CHALLENGE MATRIX
2.3 SECONDARY SOURCES
2.4 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 INCREASING CASES OF DIABETIC FOOT ULCERS
3.1.2 INCREASING INCIDENCES OF BURN CASES
3.1.3 RISING NUMBER OF GERIATRIC POPULATION
3.1.4 INNOVATION IN WOUND CARE BIOLOGICS
3.1.5 NEW PRODUCT LAUNCHES

3.2 RESTRAINS

3.2.1 HIGH COST OF WOUND TREATMENT AND WOUND CARE BIOLOGICS
3.2.2 RISK OF SKIN SUBSTITUE FAILURE

3.3 OPPORTUNITIES

3.3.1 3D SKIN PRINTING
3.3.2 AWARENESS PROGRAMS

3.4 CHALLENGES

3.4.1 LACK OF WOUND MANAGEMENT SERVICES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 GLOBAL WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE

6.1 OVERVIEW

6.2 SYNTHETIC SKIN GRAFTS

6.3 GROWTH FACTORS

6.3.1 PLATELET DERIVED GROWTH FACTOR (PDGF)
6.3.2 PLATELET RICH PLASMA (PRP)
6.3.3 EPIDERMAL GROWTH FACTORS (EGF)
6.3.4 BASIC FIBROBLAST GROWTH FACTORS (BFGF)
6.3.5 GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF)
6.3.6 TALACTOFERRIN ALFA
6.3.7 THROMBIN PEPTIDE
6.3.8 KERATINOCY GROWTH FACTOR (KGF)

6.4 ALLOGRAFTS

6.5 XENOGRAFTS

7 GLOBAL WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE

7.1 OVERVIEW

7.2 WOUNDS

7.2.1 SURGICAL WOUND

7.2.1.1 SKIN SURGERY

7.2.1.1.1 WOUND CLOSURE
7.2.1.1.2 SKIN BIOPSY
7.2.1.1.3 SKIN FLAP
7.2.1.1.4 SKIN GRAFT
7.2.1.1.5 OTHERS

7.2.1.2 COSMETIC PROCEDURE

7.2.1.2.1 BREST ENHANCEMENT
7.2.1.2.2 FACIAL CONTOURING
7.2.1.2.3 FACIAL REJUVENATION:
7.2.1.2.4 BODY CONTOURING
7.2.1.2.5 SKIN REJUVENATION
7.2.1.2.6 OTHERS

7.2.1.3 GYNECOLOGIC PROCEDURES

7.2.1.3.1 PUBOVAGINALIS SLING
7.2.1.3.2 PELVIC FLOOR RECONSTRUCTION
7.2.1.3.3 RECTOCELE REPAIR SURGERY
7.2.1.3.4 OTHERS

7.2.1.4 GASTROINTESTINAL PROCEDURE

7.2.1.4.1 GENERAL GASTROINTESTINAL SURGERY
7.2.1.4.2 HERNIA
7.2.1.4.3 OTHERS

7.2.2 ACUTE WOUNDS

7.2.3 CHRONIC WOUNDS

7.2.4 TRAUMATIC WOUNDS

7.3 BURNS

7.3.1 ULCERS
7.3.2 DIABETIC ULCERS
7.3.3 PRESSURE ULCER
7.3.4 VENOUS ULCER
7.3.5 OTHERS

8 GLOBAL WOUND CARE BIOLOGICS MARKET, BY END USER

8.1 OVERVIEW
8.2 HOSPITALS
8.3 WOUND CARE CENTERS
8.4 AMBULATORY SURGICAL CENTERS
8.5 CLINICS
8.6 COMMUNITY HEALTHCARE CENTER

9 GLOBAL WOUND CARE BIOLOGICS MARKET: GEOGRAPHY

9.1 GLOBAL

9.2 NORTH AMERICA

9.2.1 U.S.
9.2.2 CANADA
9.2.3 MEXICO

9.3 EUROPE

9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 U.K.
9.3.4 ITALY
9.3.5 SWITZERLAND
9.3.6 NETHERLANDS
9.3.7 RUSSIA
9.3.8 TURKEY
9.3.9 SPAIN
9.3.10 BELGIUM
9.3.11 REST OF EUROPE

9.4 ASIA-PACIFIC

9.4.1 CHINA
9.4.2 JAPAN
9.4.3 INDIA
9.4.4 SOUTH KOREA
9.4.5 AUSTRALIA
9.4.6 THAILAND
9.4.7 MALAYSIA
9.4.8 SINGAPORE
9.4.9 INDONESIA
9.4.10 PHILIPPINES
9.4.11 REST OF ASIA-PACIFIC

9.5 SOUTH AMERICA

9.5.1 BRAZIL
9.5.2 REST OF SOUTH AMERICA

9.6 MIDDLE EAST & AFRICA

9.6.1 SOUTH AFRICA
9.6.2 REST OF MIDDLE EAST & AFRICA

10 GLOBAL WOUND CARE BIOLOGICS MARKET, COMPANY LANDSCAPE

10.1 COMPANY SHARE ANALYSIS: GLOBAL
10.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
10.3 COMPANY SHARE ANALYSIS: EUROPE
10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

11 COMPANY PROFILE

11.1 MIMEDX.

11.1.1 COMPANY OVERVIEW
11.1.2 REVENUE ANALYSIS:
11.1.3 COMPANY SHARE ANALYSIS:
11.1.4 PRODUCT PORTFOLIO
11.1.5 RECENT DEVELOPMENTS

11.2 ORGANOGENESIS INC

11.2.1 COMPANY OVERVIEW
11.2.2 GEOGRAPHIC PRESENCE
11.2.3 COMPANY SHARE ANALYSIS:
11.2.4 PRODUCT PORTFOLIO
11.2.5 RECENT DEVELOPMENTS

11.3 INTEGRA LIFESCIENCES

11.3.1 COMPANY OVERVIEW
11.3.2 REVENUE ANALYSIS
11.3.3 COMPANY SHARE ANALYSIS:
11.3.4 PRODUCT PORTFOLIO
11.3.5 RECENT DEVELOPMENTS

11.4 CONVATEC INC.

11.4.1 COMPANY OVERVIEW
11.4.2 REVENUE ANALYSIS
11.4.3 COMPANY SHARE ANALYSIS:
11.4.4 PRODUCT PORTFOLIO :
11.4.5 RECENT DEVELOPMENTS

11.5 ACELL INC.

11.5.1 COMPANY OVERVIEW
11.5.2 PRODUCT PORTFOLIO
11.5.3 RECENT DEVELOPMENTS

11.6 ALLOSOURCE

11.6.1 COMPANY OVERVIEW
11.6.2 PRODUCT PORTFOLIO
11.6.3 RECENT DEVELOPMENTS

11.7 ALPHATEC SPINE, INC. ( A SUBSIDARY OF ALPHATEC HOLDINGS, INC)

11.7.1 COMPANY OVERVIEW
11.7.2 PRODUCT PORTFOLIO
11.7.3 RECENT DEVELOPMENTS

11.8 AMNIO TECHNOLOGY, LLC

11.8.1 COMPANY OVERVIEW
11.8.2 PRODUCT PORTFOLIO
11.8.3 RECENT DEVELOPMENTS

11.9 AMNIOX MEDICAL, INC.

11.9.1 COMPANY OVERVIEW
11.9.2 PRODUCT PORTFOLIO
11.9.3 RECENT DEVELOPMENTS

11.10 ANIKA THERAPEUTICS, INC.

11.10.1 COMPANY OVERVIEW
11.10.2 REVENUE ANALYSIS
11.10.3 PRODUCT PORTFOLIO
11.10.4 RECENT DEVELOPMENTS

11.11 BIOHORIZONS IPH, INC ( A SUBSIDARY OF HENRY SCHEIN, INC.)

11.11.1 COMPANY OVERVIEW
11.11.2 GEOGRAPHICPRESENCE
11.11.3 PRODUCT PORTFOLIO
11.11.4 RECENT DEVELOPMENTS

11.12 KERECIS

11.12.1 COMPANY OVERVIEW
11.12.2 GEOGRAPHICAL PRESENCE
11.12.3 PRODUCT PORTFOLIO
11.12.4 RECENT DEVELOPMENTS

11.13 MARINE POLYMER TECHNOLOGIES, INC

11.13.1 COMPANY OVERVIEW
11.13.2 PRODUCT PORTFOLIO
11.13.3 RECENT DEVELOPMENTS

11.14 MÖLNLYCKE HEALTH CARE AB

11.14.1 COMPANY OVERVIEW
11.14.2 REVENUE ANALYSIS
11.14.3 PRODUCT PORTFOLIO
11.14.4 RECENT DEVELOPMENTS

11.15 OSIRIS THERAPEUTICS, INC.

11.15.1 COMPANY OVERVIEW
11.15.2 REVENUE ANALYSIS
11.15.3 PRODUCT PORTFOLIO
11.15.4 RECENT DEVELOPMENTS

11.16 SKYE BIOLOGICS INC.

11.16.1 COMPANY OVERVIEW
11.16.2 PRODUCT PORTFOLIO :
11.16.3 RECENT DEVELOPMENT:

11.17 SMITH AND NEPHEW

11.17.1 COMPANY OVERVIEW
11.17.2 REVENUE ANALYSIS
11.17.3 PRODUCT PORTFOLIO
11.17.4 RECENT DEVELOPMENTS

11.18 SOLSYS MEDICAL.

11.18.1 COMPANY OVERVIEW
11.18.2 PRODUCT PORTFOLIO
11.18.3 RECENT DEVELOPMENTS

11.19 VERICEL CORPORATION.

11.19.1 COMPANY OVERVIEW
11.19.2 1.1.2 REVENUE ANALYSIS
11.19.3 PRODUCT PORTFOLIO
11.19.4 RECENT DEVELOPMENTS

11.20 WRIGHT MEDICAL GROUP N.V

11.20.1 COMPANY OVERVIEW
11.20.2 1.1.2 REVENUE ANALYSIS
11.20.3 PRODUCT PORTFOLIO
11.20.4 RECENT DEVELOPMENTS

12 RELATED REPORTS

표 목록

LIST OF TABLES GLOBAL WOUND CARE BIOLOGICS MARKET

TABLE 1 GLOBAL WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE, 2016– 2025 (USD MILLION)

TABLE 2 GLOBAL SYNTHETIC SKIN GRAFTS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)

TABLE 3 GLOBAL GROWTH FACTORS IN WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE, 2016– 2025 (USD MILLION)

TABLE 4 GLOBAL GROWTH FACTORS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)

TABLE 5 GLOBAL ALLOGRAFTS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)

TABLE 6 GLOBAL XENOGRAFTS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)

TABLE 7 GLOBAL WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE, 2015– 2025 (USD MILLION)

TABLE 8 GLOBAL WOUNDS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)

TABLE 9 GLOBAL WOUNDS IN WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE, 2016– 2025 (USD MILLION)

TABLE 10 GLOBAL SURGICAL WOUND IN WOUND CARE BIOLOGICS MARKET, 2016-2025 (USD MILLION)

TABLE 11 GLOBAL SKIN SURGERY IN WOUND CARE BIOLOGICS MARKET, 2016-2025 (USD MILLION)

TABLE 12 NUMBER OF COSMETIC SURGERY, 2016 & 2017

TABLE 13 GLOBAL COSMETIC SURGERY IN WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE, 2016-2025 (USD MILLION)

TABLE 14 GLOBAL GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE, 2016-2025 (USD MILLION)

TABLE 15 GLOBAL GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE 2018-2025 (USD MILLION)

TABLE 16 GLOBAL BURNS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)

TABLE 17 GLOBAL ULCERS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)

TABLE 18 GLOBAL ULCERS IN WOUND CARE BIOLOGICS MARKET, BY WOUND TYPE 2016-2025 (USD MILLION)

TABLE 19 GLOBAL WOUND CARE BIOLOGICS MARKET, BY END USER, 2016 – 2025 (USD MILLION)

TABLE 20 GLOBAL HOSPITALS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)

TABLE 21 GLOBAL WOUND CARE CENTER IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)

TABLE 22 STATISTICS FOR AMBULATORY SURGICAL CENTER. U.S.

TABLE 23 GLOBAL AMBULATORY SURGICAL CENTERS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)

TABLE 24 GLOBAL CLINICS IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)

TABLE 25 GLOBAL COMMUNITY HEALTHCARE CENTER IN WOUND CARE BIOLOGICS MARKET, BY REGION, 2016– 2025 (USD MILLION)

TABLE 26 GLOBAL WOUND CARE BIOLOGICS MARKET, BY GEOGRAPHY, USD MILLION (2016-2025)

TABLE 27 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY, 2016-2025 (USD MILLION )

TABLE 28 NORTH AMERICA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 29 NORTH AMERICA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 30 NORTH AMERICA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 31 NORTH AMERICA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 32 NORTH AMERICA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 33 NORTH AMERICA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 34 NORTH AMERICA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 35 NORTH AMERICA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 36 NORTH AMERICA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 37 NORTH AMERICA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 38 NORTH AMERICA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 39 U.S. WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 40 U.S. GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 41 U.S. WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 42 U.S. WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 43 U.S. SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 44 U.S. SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 45 U.S. COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 46 U.S. GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 47 U.S. GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 48 U.S. ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 49 U.S. WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 50 CANADA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 51 CANADA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 52 CANADA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 53 CANADA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 54 CANADA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 55 CANADA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 56 CANADA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 57 CANADA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 58 CANADA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 59 CANADA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 60 CANADA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 61 MEXICO WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 62 MEXICO GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 63 MEXICO WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 64 MEXICO WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 65 MEXICO SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 66 MEXICO SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 67 MEXICO COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 68 MEXICO GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 69 MEXICO GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 70 MEXICO ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 71 MEXICO WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 72 EUROPE WOUND CARE BIOLOGICS MARKET, BY COUNTRY, USD MILLION (2016-2025)

TABLE 73 EUROPE WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 74 EUROPE GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 75 EUROPE WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 76 EUROPE WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 77 EUROPE SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 78 EUROPE SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 79 EUROPE COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 80 EUROPE GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 81 EUROPE GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 82 EUROPE ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 83 EUROPE WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 84 GERMANY WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 85 GERMANY GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 86 GERMANY WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 87 GERMANY WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 88 GERMANY SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 89 GERMANY SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 90 GERMANY COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 91 GERMANY GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 92 GERMANY GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 93 GERMANY ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 94 GERMANY WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 95 FRANCE WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 96 FRANCE GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 97 FRANCE WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 98 FRANCE WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 99 FRANCE SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 100 FRANCE SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 101 FRANCE COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 102 FRANCE GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 103 FRANCE GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 104 FRANCE ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 105 FRANCE WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 106 U.K. WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 107 U.K. GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 108 U.K. WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 109 U.K. WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 110 U.K. SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 111 U.K. SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 112 U.K. COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 113 U.K. GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 114 U.K. GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 115 U.K. ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 116 U.K. WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 117 ITALY WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 118 ITALY GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 119 ITALY WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 120 ITALY WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 121 ITALY SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 122 ITALY SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 123 ITALY COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 124 ITALY GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 125 ITALY GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 126 ITALY ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 127 ITALY WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 128 SWITZERLAND WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 129 SWITZERLAND GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 130 SWITZERLAND WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 131 SWITZERLAND WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 132 SWITZERLAND SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 133 SWITZERLAND SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 134 SWITZERLAND COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 135 SWITZERLAND GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 136 SWITZERLAND GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 137 SWITZERLAND ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 138 SWITZERLAND WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 139 NETHERLANDS WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 140 NETHERLANDS GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 141 NETHERLANDS WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 142 NETHERLANDS WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 143 NETHERLANDS SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 144 NETHERLANDS SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 145 NETHERLANDS COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 146 NETHERLANDS GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 147 NETHERLANDS GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 148 NETHERLANDS ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 149 SWITZERLAND WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 150 RUSSIA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 151 RUSSIA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 152 RUSSIA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 153 RUSSIA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 154 RUSSIA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 155 RUSSIA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 156 RUSSIA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 157 RUSSIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 158 RUSSIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 159 RUSSIA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 160 RUSSIA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 161 TURKEY WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 162 TURKEY GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 163 TURKEY WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 164 TURKEY WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 165 TURKEY SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 166 TURKEY SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 167 TURKEY COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 168 TURKEY GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 169 TURKEY GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 170 TURKEY ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 171 TURKEY WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 172 SPAIN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 173 SPAIN GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 174 SPAIN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 175 SPAIN WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 176 SPAIN SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 177 SPAIN SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 178 SPAIN COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 179 SPAIN GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 180 SPAIN GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 181 SPAIN ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 182 SPAIN WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 183 BELGIUM WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 184 BELGIUM GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 185 BELGIUM WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 186 BELGIUM WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 187 BELGIUM SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 188 BELGIUM SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 189 BELGIUM COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 190 BELGIUM GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 191 BELGIUM GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 192 BELGIUM ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 193 BELGIUM WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 194 REST OF EUROPE WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 195 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET, BY COUNTRY, 2016-2025, (USD MILLION)

TABLE 196 ASIA-PACIFIC WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 197 ASIA-PACIFIC GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 198 ASIA-PACIFIC WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 199 ASIA-PACIFIC WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 200 EUROPE SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 201 ASIA-PACIFIC SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 202 ASIA-PACIFIC COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 203 ASIA-PACIFIC GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 204 ASIA-PACIFIC GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 205 ASIA-PACIFIC ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 206 ASIA-PACIFIC WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 207 CHINA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 208 CHINA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 209 CHINA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 210 CHINA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 211 CHINA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 212 CHINA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 213 CHINA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 214 CHINA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 215 CHINA GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 216 CHINA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 217 CHINA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 218 JAPAN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 219 JAPAN GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 220 JAPAN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 221 JAPAN WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 222 JAPAN SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 223 JAPAN SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 224 JAPAN COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 225 JAPAN GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 226 JAPAN GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 227 JAPAN ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 228 JAPAN WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 229 INDIA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 230 INDIA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 231 INDIA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 232 INDIA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 233 INDIA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 234 INDIA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 235 INDIA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 236 INDIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 237 INDIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 238 INDIA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 239 INDIA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 240 SOUTH KOREA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 241 SOUTH KOREA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 242 SOUTH KOREA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 243 SOUTH KOREA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 244 SOUTH KOREA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 245 SOUTH KOREA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 246 SOUTH KOREA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 247 SOUTH KOREA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 248 SOUTH KOREA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 249 SOUTH KOREA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 250 SOUTH KOREA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 251 AUSTRALIA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 252 AUSTRALIA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 253 AUSTRALIA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 254 AUSTRALIA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 255 AUSTRALIA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 256 AUSTRALIA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 257 AUSTRALIA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 258 AUSTRALIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 259 AUSTRALIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 260 AUSTRALIA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 261 AUSTRALIA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 262 THAILAND WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 263 THAILAND GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 264 THAILAND WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 265 THAILAND WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 266 THAILAND SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 267 THAILAND SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 268 THAILAND COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 269 THAILAND GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 270 THAILAND GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 271 THAILAND ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 272 THAILAND WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 273 MALAYSIA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 274 MALAYSIA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 275 MALAYSIA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 276 MALAYSIA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 277 MALAYSIA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 278 MALAYSIA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 279 MALAYSIA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 280 MALAYSIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 281 MALAYSIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 282 MALAYSIA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 283 MALAYSIA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 284 SINGAPORE WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 285 SINGAPORE GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 286 SINGAPORE WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 287 SINGAPORE WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 288 SINGAPORE SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 289 SINGAPORE SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 290 SINGAPORE COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 291 SINGAPORE GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 292 SINGAPORE GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 293 SINGAPORE ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 294 SINGAPORE WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 295 INDONESIA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 296 INDONESIA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 297 INDONESIA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 298 INDONESIA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 299 INDONESIA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, “2016-2025, (USD MILLION)

TABLE 300 INDONESIA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 301 INDONESIA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 302 INDONESIA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 303 PHILIPPINESGYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 304 INDONESIA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 305 INDONESIA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 306 PHILIPPINES WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 307 PHILIPPINES GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 308 PHILIPPINES WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 309 PHILIPPINES WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 310 PHILIPPINES SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 311 PHILIPPINES SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 312 PHILIPPINES COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 313 PHILIPPINES GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 314 PHILIPPINESGYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 315 PHILIPPINES ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 316 PHILIPPINESWOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 317 REST OF ASIA-PACIFIC WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 318 SOUTH AMERICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY, USD MILLION (2016-2025)

TABLE 319 SOUTH AMERICA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 320 SOUTH AMERICA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 321 SOUTH AMERICA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 322 SOUTH AMERICA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 323 SOUTH AMERICA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 324 SOUTH AMERICA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 325 SOUTH AMERICA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 326 SOUTH AMERICA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 327 SOUTH AMERICA GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 328 SOUTH AMERICA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 329 SOUTH AMERICA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 330 BRAZIL WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 331 BRAZIL GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 332 BRAZIL WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 333 BRAZIL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 334 BRAZIL SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 335 BRAZIL SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 336 BRAZIL COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 337 BRAZIL GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 338 BRAZIL GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 339 BRAZIL ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 340 BRAZIL WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 341 REST OF SOUTH AMERICA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 342 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY, USD MILLION (2016-2025)

TABLE 343 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 344 MIDDLE EAST & AFRICA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 345 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 346 MIDDLE EAST & AFRICA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 347 MIDDLE EAST & AFRICA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 348 MIDDLE EAST & AFRICA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 349 MIDDLE EAST & AFRICA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 350 MIDDLE EAST & AFRICA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 351 MIDDLE EAST & AFRICA GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 352 MIDDLE EAST & AFRICA GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 353 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 354 SOUTH AFRICA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 355 SOUTH AFRICA GROWTH FACTORS IN WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

TABLE 356 SOUTH AFRICA WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 357 SOUTH AFRICA WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 358 SOUTH AFRICA SURGICAL WOUNDS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 359 SOUTH AFRICA SKIN SURGERY IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 360 SOUTH AFRICA COSMETIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 361 SOUTH AFRICA GYNECOLOGIC PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 362 SOUTH AFRICA GASTROINTESTINAL PROCEDURES IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 363 SOUTH AFRICA ULCERS IN WOUND CARE BIOLOGICS, BY WOUND TYPE, 2016-2025, (USD MILLION)

TABLE 364 SOUTH AFRICA WOUND CARE BIOLOGICS, BY END USER, 2016-2025, (USD MILLION)

TABLE 365 REST OF MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS, BY PRODUCT TYPE, 2016-2025, (USD MILLION)

그림 목록

LIST OF FIGURES GLOBAL WOUND CARE BIOLOGICS MARKET

FIGURE 1 GLOBAL WOUND CARE BIOLOGICS MARKET: SEGMENTATION

FIGURE 2 GLOBAL WOUND CARE BIOLOGICS MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL WOUND CARE BIOLOGICS MARKET: RESEARCH SNAPSHOT

FIGURE 4 GLOBAL WOUND CARE BIOLOGICS MARKET: BOTTOM UP APPROACH

FIGURE 5 GLOBAL WOUND CARE BIOLOGICS MARKET: TOP DOWN APPROACH

FIGURE 6 GLOBAL WOUND CARE BIOLOGICS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 1 GLOBAL WOUND CARE BIOLOGICS MARKET: DBMR MARKET POSITION GRID

FIGURE 2 GLOBAL WOUND CARE BIOLOGICS MARKET: THE MARKET CHALLENGE MATRIX

FIGURE 3 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL WOUND CARE BIOLOGICS MARKET

FIGURE 4 AGING POPULATION IN DIFFERENT COUNTRIES (2014, 2017 & 2020)

FIGURE 5 GLOBAL WOUND CARE BIOLOGICS MARKET: SEGMENTATION

FIGURE 6 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL WOUND CARE BIOLOGICS MARKET AND ASIA PACIFIC IS ESTIMATED TO BE INCREASING WITH THE STRONG CAGR IN THE FORECAST PERIOD FROM 2018 TO 2025

FIGURE 7 INCREASING PREVELANCE OF DIABETIC FOOT ULCERS AND INCREASING INCIDENCES OF BURN CASES ARE EXPECTED TO DRIVE THE MARKET FOR GLOBAL WOUND CARE BIOLOGICS IN THE FORECAST PERIOD 2018 TO 2025

FIGURE 8 SYNTHETIC SKIN GRAFTS IN GLOBAL WOUND CARE BIOLOGICS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL WOUND CARE BIOLOGICS MARKET IN 2018 & 2025

FIGURE 9 ASIA PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR GLOBAL WOUND CARE BIOLOGICS MARKET IN THE FORECAST PERIOD FROM 2018 TO 2025 62

FIGURE 10 WORLDWIDE PREVALENCE OF VARIOUS WOUND TYPES, 2011

FIGURE 11 CASES OF BURN INJURIES, (2009 – 2012)

FIGURE 12 PREVALENCE OF PRESSURE ULCERS IN FEW COUNTRIES

FIGURE 13 NUMBER OF SURGICAL PROCEDURES AND SURGICAL SITE INFECTIONS

FIGURE 14 GLOBAL WOUND CARE BIOLOGICS MARKET: BY PRODUCT TYPE, 2017

FIGURE 15 GLOBAL WOUND CARE BIOLOGICS MARKET: BY WOUND TYPE, 2017

FIGURE 16 GLOBAL WOUND CARE BIOLOGICS MARKET: BY END USER, SNAPSHOT 2017

FIGURE 17 GLOBAL WOUND CARE BIOLOGICS MARKET: SNAPSHOT (2017)

FIGURE 18 GLOBAL WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2017)

FIGURE 19 GLOBAL WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2018 & 2025)

FIGURE 20 GLOBAL WOUND CARE BIOLOGICS MARKET, BY COUNTRY (2017 & 2025)

FIGURE 21 GLOBAL WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE (2018 -2025)

FIGURE 22 NORTH AMERICA WOUND CARE BIOLOGICS MARKET: SNAPSHOT (2017)

FIGURE 23 NORTH AMERICA WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2017)

FIGURE 24 NORTH AMERICA WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2018 & 2025)

FIGURE 25 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY (2017 & 2025)

FIGURE 26 NORTH AMERICA WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE (2018 -2025)

FIGURE 27 EUROPE WOUND CARE BIOLOGICS MARKET: SNAPSHOT (2017)

FIGURE 28 EUROPE WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2017)

FIGURE 29 EUROPE WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2018 & 2025)

FIGURE 30 EUROPE WOUND CARE BIOLOGICS MARKET, BY COUNTRY (2017 & 2025)

FIGURE 31 EUROPE WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE (2018 -2025)

FIGURE 32 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET: SNAPSHOT (2017)

FIGURE 33 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2017)

FIGURE 34 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2018 & 2025)

FIGURE 35 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET, BY COUNTRY (2017 & 2025)

FIGURE 36 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE (2018 -2025)

FIGURE 37 SOUTH AMERICA WOUND CARE BIOLOGICS MARKET: SNAPSHOT (2017)

FIGURE 38 SOUTH AMERICA WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2017)

FIGURE 39 SOUTH AMERICA WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2018 & 2025)

FIGURE 40 SOUTH AMERICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY (2017 & 2025)

FIGURE 41 SOUTH AMERICA WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE (2018 -2025)

FIGURE 42 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET: SNAPSHOT (2017)

FIGURE 43 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2017)

FIGURE 44 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET: BY COUNTRY (2018 & 2025)

FIGURE 45 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET, BY COUNTRY (2017 & 2025)

FIGURE 46 MIDDLE EAST & AFRICA WOUND CARE BIOLOGICS MARKET, BY PRODUCT TYPE (2018 -2025)

FIGURE 47 GLOBAL WOUND CARE BIOLOGICS MARKET: COMPANY SHARE 2017 (%)

FIGURE 48 NORTH AMERICA WOUND CARE BIOLOGICS MARKET: COMPANY SHARE 2017 (%)

FIGURE 49 EUROPE WOUND CARE BIOLOGICS MARKET: COMPANY SHARE 2017 (%)

FIGURE 50 ASIA-PACIFIC WOUND CARE BIOLOGICS MARKET: COMPANY SHARE 2017 (%)

자세한 정보 보기

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.